Latest operating income for HSCSW: $-1.9B.
Get informed when a big investor buys or sells
+ FollowAs of Jul 31, 2026
Trailing 12 months ending Jul 31, 2026
As of the most recent data (July 2026), HSCSW shows a operating income of $-1.9B. That compares with $-6.4B in the prior-year period — up 70.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HSCSW's operating income is now $-1.9B (was $-6.4B) — a 70.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Heart Test Laboratories - Warrants(15/06/2027) is outperforming or lagging.
Tracking HSCSW's operating income over time shows whether Heart Test Laboratories - Warrants(15/06/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $-1.9B That compares with $-6.4B in the prior-year period — up 70.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Heart Test Laboratories - Warrants(15/06/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-1.9B) with ownership activity and broader fundamentals.